TransMedics Group, Inc., headquartered in Andover, Massachusetts, is a medical technology company revolutionizing organ transplant therapy for patients with end-stage heart, lung, and liver failure. Their flagship product, the Organ Care System (OCS), is a portable device that maintains donor organs in a near-living state outside the human body, enabling optimal preservation and assessment prior to transplantation. This innovative approach aims to increase the availability and viability of donor organs, improving patient outcomes and expanding access to life-saving transplants. TransMedics continues to advance its technology to address the limitations of traditional organ preservation methods, striving to transform the standard of care in organ transplantation.